Dr. Challen, Professor of Medicine in the Division of Oncology is a 2023 Leukemia & Lymphoma Society-Career Development Program Scholar Achievement Awardee. Dr. Challen’s laboratory research aims to determine how disruption of the chemical compounds that direct our genome leads to the development of blood cancers including important work in understanding how mutations in the DNMT3A gene regulate the balance of self-renewal and differentiation of blood stem cells as a first step to development of AML.
Grant Challen, PhD Receives Prestigious LLS Career Development Achievement Award
View Content